Lupin inches up on securing UK regulator’s nod for Yinzell & Levonorgestrel contraceptives

15 Apr 2014 Evaluate

Lupin is currently trading at Rs. 950.25, up by 1.60 points or 0.17% from its previous closing of Rs. 948.65 on the BSE.

The scrip opened at Rs. 951.00 and has touched a high and low of Rs. 953.70 and Rs. 939.20 respectively. So far 24471 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1003.00 on 03-Mar-2014 and a 52 week low of Rs. 638.25 on 12-Apr-2013.

Last one week high and low of the scrip stood at Rs. 983.80 and Rs. 947.50 respectively. The current market cap of the company is Rs. 42595.70 crore.

The promoters holding in the company stood at 46.75 % while Institutions and Non-Institutions held 43.17 % and 10.08 % respectively.

Pharma Major Lupin has received UK regulator’s nod for Yinzell & Levonorgestrel Contraceptives. Levonorgestrel is a medicine which is used in contraception. Levonorgestrel contains two hormones that are similar to the hormonesoestrogen and progesterone that are produced by the body. Levonorgestrel is used to prevent women from becoming pregnant.

Recently, the company received US Food and Drug Administration (US FDA) nod for Pioglitazone Hydrochloride Tablets. Pioglitazone tablets are to treat high blood sugar associated with diabetes.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations and APIs globally.

Lupin Share Price

1580.00 -0.55 (-0.03%)
24-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1486.35
Dr. Reddys Lab 5962.50
Cipla 1400.00
Zydus Lifesciences 933.40
Lupin 1580.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.